1. Home
  2. HMH vs CRBP Comparison

HMH vs CRBP Comparison

Compare HMH & CRBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo HMH Holding Inc. Class A Common Stock

HMH

HMH Holding Inc. Class A Common Stock

N/A

Current Price

$18.56

Market Cap

237.2M

ML Signal

N/A

CRBP

Corbus Pharmaceuticals Holdings Inc.

N/A

Current Price

$4.18

Market Cap

190.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
HMH
CRBP
Founded
2021
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Oil and Gas Field Machinery
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
237.2M
190.3M
IPO Year
2024
2014

Fundamental Metrics

Financial Performance
Metric
HMH
CRBP
Price
$18.56
$4.18
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
10
Target Price
$28.71
★ $34.89
AVG Volume (30 Days)
139.6K
★ 860.0K
Earning Date
11-04-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ 1.26
N/A
Revenue
N/A
★ $4,822,272.00
Revenue This Year
N/A
N/A
Revenue Next Year
$18.81
$131.00
P/E Ratio
$14.81
★ N/A
Revenue Growth
N/A
★ 97.62
52 Week Low
$16.51
$3.87
52 Week High
$22.34
$12.88

Technical Indicators

Market Signals
Indicator
HMH
CRBP
Relative Strength Index (RSI) 52.47 24.93
Support Level $18.30 N/A
Resistance Level $20.16 $8.13
Average True Range (ATR) 0.83 0.32
MACD 0.15 0.12
Stochastic Oscillator 76.60 21.58

Price Performance

Historical Comparison
HMH
CRBP

About HMH HMH Holding Inc. Class A Common Stock

HMH Holding Inc is a provider of offshore and onshore drilling equipment and services in the United States and Norway. Its services include sales of projects and products including drilling equipment packages for newbuild or a reactivated drilling rig, and individual or grouped components of drilling and pressure control equipment. The company also offers aftermarket services including services and replacement parts on installed equipment and integrated digital solutions. The company sells equipment and services to drilling contractors; operators, including both oil and gas E&P companies and mining companies onshore and offshore; and manufacturers, consisting of shipyards.

About CRBP Corbus Pharmaceuticals Holdings Inc.

Corbus Pharmaceuticals Holdings Inc is a clinical stage company focused on new therapies in oncology and obesity and is committed to helping people defeat serious illness by bringing inventive scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.

Share on Social Networks: